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Abstract

Introduction

Human alpha interferons (IFN - a) cause a reorganization of internal cell membranes into tubuloreticular inclusions (TRI). Morphogenesis and cytochemistry indicate a pre-Golgi intracisternal origin
from the endoplasmic reticulum.
Clinically, TRI
formation in human blood mononuclear cells correlates with systemic IFN-a treatment or with endogenous overproduction of IFN - a in viral or autoimmune
diseases (e.g., rubella syndrome, AIDS, systemic lupus
erythematosus). In vitro, TRI formation can be pro duced by treatment of Daudi lymphoblasts or vascular
endothelial cells with IFN - a, and is blocked by actin omycin-D. In Daudi lymphoblasts or vascular endothelial cell cultures, TRI formation parallels induction
of 2' - 5' A synthetase, inhibition of thymidine kinase
and growth inhibition; however , heavy water treatment of Daudi cells prevented TRI formation while
induction of 2 '-5' A synthetase and growth inhibition
persisted. TRI formation was dissociated from IFN-a
antiproliferative activity in a mutant clone of Daudi
lymphoblasts. Decreased glycoprotein biosynthesis
and increased phospholipid biosynthesis may accompany progressive TRI accumulation.

Ultrastructure of TRI
Incubation of lymphocytes, monocytes, or vascular endothelial cells with human type I interferons
(alpha or beta) induces a characteristic change in the
ultrastructure of pre-Golg-i cytomembranes in
human12 , 17,21,26,46,41 , apeTB and monkey cellsll.
The rough endoplasmic reticulum (ER) and perinuclear envelope appear to be primary targets of this
interferon effect21, but annulate lamellae and the
transitional complex of ER - Golg-i membranes can also
be sites of TRI formation21,\r6,46.
The essential
feature is accumulation of intracisternal membranous
tubules which range from 22-28 nm diameter (Figs. 1,
2).
These generally have been referred to as
"tubuloreticular" inclusions or "TRI 11 22.
In non-human primate cells exposed to human
alpha interferon (IFN-a), the membranous tubular
elements often form compact, paracrystalline arrays
within expanded cisternae of the ERll,78 (Fig. 2).
Even before the causation of TRI by IFN-a was established , it had been proposed that the paracrystalline membranous arrays in animal cells represented a
functional variation of the loosely configured TRI
found in human cells63, 79. This hypothesis has been
confirmed in recent studies of rhesus monkey placental cellsll and of baboon lymphoblasts (Feldman, D,
Grimley, PM, unpublished observations): both theirregular tubular meshworks and the geometric paracrystalline arrays develop in response to human IFa
treatment (Figs. 3, 4).
Morphogenesis of TRI
In human cells, TRI appear to originate as multiple, branching invaginations of the membrane bilayers bounding the ER or perinuclear cisternae (Fig . 1).
The earliest tubule formation begins in the perinuclear region21. In Daudi lymphoblasts very loose networks of intracisternal membranous tubules develop
within 12 to 24 hours after exposure to IFN-a in
vitro21. These networks gradually become larger and
more compact during prolonged IFN-a stimulation,
but the tubular branching remains irregular. Blood
lymphocytes develop TRI within 24 hours after IFN-a
treatment in vitro or in vivo.
These are usually
smaller and-more compact than the accumulations observed in lymphoblastsl 7 but occasional "loose forms"
are also identified. Regions of TRI developing in
vascular endothelial cell cultures also are very small
at initial observation; they tend to enlarge over a
period of days12. In monkey cells, even the smallest
regions of TRI typically
exhibit a geometric
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Fig. 1. Early TRI formation
intracisternal 25 nm mem branous tubules in Daudi lymphoblast, 12 hours after
treatment with IFN -a ( 500 IU /m l) .
Note proximity to
perinuclear cisternum (arrow).
Fig. 2. Typical network of TRI in a human lymphoblast
after treatment with IFN -a (500 IU/ml) for 24 hours.
Fig. 3. TRI in placental fibroblast of rhesus monkey follow mg systematic treatment with IFN-all. Note features
indistinguishable from the TRI in human calls.
Fig. 4. Paracrystalline array of membranous tubules expandmg cisternum of ER in placental capillary endothelium
of a rhesus monkey following systematic treatment with
IFN-all.
Fig. 5. Cytochemical reaction for acetyl cholinesterase37
mperipheral blood lymphocyte from patient with AIDS
and elevated serum IFN-a. Electron-dense deposits highlight the ER, perinuclear envelope (arrow) and region with
TRI.
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paracrystalline configuration 11.
Ultrastructural Cytochemistry of TRI
Initial cytochemical digestion studies disclosed
that TRI contain lipid and trypsin-resistant acidic
protein components77. Nucleic acid was not detected
by selective digestion, ion labelling, or autoradiographic techniques22, 77. Additional enzyme cytochemical studies now indicate that reactions for several enzymes typically associated with the ER also
are positive in regions of TRI (Table 1, Fig. 5), and
suggest that ER-associated enzyme proteins must insert into membranes comprising TRI during or after
morphogenesis.

Table 1.

Cytochemistry of TRI

Selective Fixation

Method

Result
+
+

Osmium-ferricyanide19
KMnO4 74
Selective Staining
UAc - EDTA (RNA)77
Ag - proteinate (glycogen) 22
Chromic-acid PTA (mucoprotein) 77

+

Experimental Induction of TRI in Cell Structures
Selective Extraction 7 4
Experimental induction of TRI has been demonstrated in short term cultures of human peripheral
blood lymphocytes! 7 ,47, in cultures of continuous
lymphoblastoid cell lines (B-cell or T-cell origin), and
in cultures of human endothelial cellsl2,51.
The
initial model for TRI induction involved treatment of
lymphoblastoid cell cultures with halogenated
pyrimidinesl6,24,28, and TRI formation was related to
S-phase incorporation of BUdR28. Subsequent work
demonstrated that the effects observed were secondary to induction of potent lymphoblast IFN-a70,71,86.
Human Blood Lymphocytes
TRI developed in short term cultures of unstimulated peripheral blood lymphocytes (PBL) exposed to
IFN-a. These included both B cells and T cells, as
demonstrated by immunoperoxidase staining32. Blas togenic doses of either Concanavalin A (Con A) or
pokeweed mitogen before IFN-a treatment increased
the apparent size and frequency of TRI in thin sec tions 7,47. TRI also developed in PBL experimentally
incubated with Staphylococcus aureus , Cowan type
146 or with UV-inactivated Sendai virusl 7. In each
of the latter conditions autogenous IF N-a was
producedl7,46.
Human Lymphoblastoid Cell Lines
TRI have been induced in human lymphoblastoid
cell lines of diverse origins, including lines which
express a B-cell phenotype or a T-cell phenotype21.
Efforts to induce TRI in the histiocytic cell line U 9374,68 were unsuccessfu121. Initial studies with halogenated pyrimidines had demonstrated that neither
the source of B cell (neoplastic or non-neoplastic)
nor the burden of EB virus genomes were critical
factors in TRI induction22. This was subsequently
confirmed by direct IFN-a treatment of several B
cell and T cell lines21. Recently, induction of TRI
has been observed in two additional B-cell lines (DG75 and Ramos) which are free of EB virus2 ,41 and in
a T-cell line (H-9) which carries no known retroviruses64. Infection of the latter with HIV -1 exerted
no major effect on TRI formation by IFN-a
(Orenstein J, Grimley PM, unpublished data).
The earliest formation of TRI has been observed
in Daudi lymphoblasts treated for 12 hours with 500
to 1000 IU/ml of IFN-a21. In a dose range of 10 to
1000 IU /ml of IFN-a, maximum accumulation of TRI
occurs within 48 to 96 hours21. Differences in cell
line sensitivity have been noted: The B cell lines
Daudi, Raji and SB are more sensitive than Namalwa
or BJAB, while the T cell lines HSB2 or H-9 are
more sensitive than Molt or CCRF-CEM. The monocytic line U-937 is a "non-responder 11 21, despite the
presence of more numerous type I receptors than

RNAase
DNAase
Pronase
Pepsin (peptide links)
Trypsin (basic proteins)

+
+

Results

Enzyme Reactions
Acid phosphatase
Guanylate cyclase
Acetyl cholinesterase
Glucose 6-phosphatase
Peroxidase
Catalase

59
35
37
36
33
34

+
+
+
+

Sources of previous data are cited following each
procedure. References for new experiments are cited
under "Method". For these procedures, Daudi cells
were treated with 300 IU /ml of IF a for 48 to 72
hours. Approximately 5 x 10-6 Daudi cells were sedimented at 400 x g, washed x 1 with ice cold serum
free medium, then fixed in ice cold 2 % glutaraldehyde
and 1 % paraformaldehyde in O. lM sodium cacodylate
buffer (pH 7 .2). Duration of fixation was 15 to 20
min for localization of glucose-6-phosphatase and 5
to 8 min for localization of guanylate cyclase or
acetyl cholinesterase.
After fixation, cells were
rinsed x 3 in buffer and stored 4 C for up to 12
hours. Reaction mixtures and incubation procedures
are given in references 33-37 and 59.
Daudi cells (Zoon, KC, personal communication).
Lymphocytes from Non-Human Primates
New mveshgahons have included electron
microscopy of chimpanzee or rhesus monkey lymphocytes in short term cultures, and of continuous lines
of lymphoblasts from the baboon (Papio hamadryas,
ATCC CRL 1494, chronically infected with a herpesvirus papio) or old world Stump tail monkey ( GM
3442). In chimpanzee or monkey lymphocytes, IFN-a
(500 IU /ml for 76-92 hours) induced the loose form
of TRI12, whereas the paracrystalline forms (similar
to type in Fig. 4) developed in the baboon and old
world monkey cells incubated with IFN-a (100 to
1000 IU /ml for 48-72 hours).
Endothelial Cells
Recent studies of early passage subcultures of
well differentiated human endothelial cells demonstrated induction of TRI in endothelial cells of
venous (umbilical cord) or arterial (thoracic aorta)
origins12. Both IFN-a12 and beta interferon51 have
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proven active on umbilical cord venous endothelium.
With IFN-a, TRI developed as early as after 48 hours
of treatment and persisted for up to at least seven
days of treatment. Apparent frequency and size of
the TRI in thin sections generally showed a positive
correlation both with the IFN-a concentration in a
range of 500 to 2000 IU/ml, and the duration of exposure. In contrast to findings in rhesus monkeys
treated systemically with IFN-all, (see below), the
TRI in human endothelial cells were never paracrystalline.
Current Limitations of Quantitation of TRI
A persistent 1mped1ment to quantitative investi gations of TRI is the lack of discrete immunocytoc hemical or biochemical markers.
Although the
aggregates of TRI can measure up to 2 .5 micrometers
maximum dimension, there is yet no discrete tech nique for recognizing them in the range of iight
optical resolution. Transmission electron microscopy
remains the only tool for definitive and quantitative
identification. Both experimental and clinical analy ses therefore must rely on labor intensive thin sec tion counts which are subject to binomial statistics18, 70. At least 200 thin sections must be examined per experimental time point to determine binomially significant differences, preferably with serial
sets of data points , as in dose effect or kinetic
studies12,21,28, 70.
TRI Formation During Clinical IFN-a Therapy
Clinical trials of IFN -a therapy and pharmaco logic tests have provided useful materials for invest igating TRI formation in intac t organisms. This is
important because an extensive body of experimental
veterinary and clinical lit erature (reviewed in reference 22), previously had illustrated TRI in a variety
of cell types and a number of experimental or dis ease c onditions . Viral infection appeared to be a
major common denominator22,28,63 and the possibility
of a relatively low molecular weight serum factor
was suspected in the pathogenesis of TRI in congenital autoimmune disease43,5U.
Peripheral Blood Mononuclear Cells (PBMC)
Several series of patients with chronic viral
infections or neoplasia have been systematically
treated with high doses of IFN-al0,66,67. In chronic
hepatitis type B and in hairy cell leukemia, TRI have
been noted in circulating lymphocytes and in other
PBMc17,26.
In PBMC samples from patients with
chronic hepatitis, immunoperoxidase studies to identify T-cells, B-cells, NK-cells and monocytes disclosed
that TRI formed in all subsets; there appeared to be
no preferential target populationl 7. Comprehensive
pre-treatment and post-treatment quantitative evaluations were conducted: pellets of PBMC were examined
under standard conditions. TRI developed within 24
hours after commencement of treatment, persisted
and increased slightly during a two week regimen of
therapy (up to 10% of sections), then entirely disappeared within 3-11 days after termination of therapy.
Endothelial cells
In contrast to pellets of PBMC which lend
themselves to random thin section examination and
statistical evaluation of morphological data, the
variable orientation of flat endothelial cells lining
tissue capillaries complicates quantitative analyses.
Moreover, serial biopsies of capillary rich tissues
such as liver or renal glomeruli may not be medically
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indicated during IFN-a therapy. Despite these problems, TRI were detected in hepatic endothelial and
Kupffer cells in liver biopsies from two patients
undergoing IF N-a therapy trials80, and in endothelial
cells of a teratoma from a patient treated with IFNa 72.
Studies after recombinant human IFN-a treatment of pregnant rhesus monkeys provided a unique
opportunity to examine effects on the blood vascula turell: electron microscopy of placental chronic villi
disclosed abundant TRI both in capillary endothelium
(Fig. 4) and in the stromal Hofbauer cells and
fibroblasts (Fig. 3); TRI were not found in control
specimens.
Interferon toxicity
TRI formation in vivo may be associated with
cytotoxic viral infectioris2J, 38; however, there has
been no direct evidence of toxic clinical effects on
the mononuclear or endothelial cell targets of TRI
formationll,17. Clinical and in vitro studies of TRI
morphogenesis also have provided no indication that
the formation of TRI heralds cytotoxicity. TRI can
form during active growth of lymphoblastoid cell
cultures21 and there was no morphologic evidence of
cytotoxicity in endothelial cell culturesl 2.
Multiple converging profiles of endoplasmic
reticulum develop in the hepatic cells of fetal mice
after hepatotoxic exposure to mouse IFN-a and have
been related to TRI56,57, but intracisternal tubular
structures evidently do not develop. Cylindrical confronting cisternae (CCC) caused by internal fusions
of the ER3,44 ,7 5 have also been associated with clinically high levels of IFN -a6 0,82, but their specificity
and reversibility is not certain44_ Experimental considerations of IFN-a and a long duration of incubation are required (1000 IU / 72 hours) to produce CCC
in Daudi cells3. In our experience these conditions
are irreversibly cytotoxic. In AIDS, CCC are considered an ultrastructural marker3,60,82 and occur in
conjunction with TRI3,60,82; however , the clinical
development of CCC is associated with terminal
disease60.
Experimental Modulation of TRI Formation
Studies with metabolic inhibitors in the Daudi
lymphoblast model have provided a few clues to
molecular mechanisms involved in TRI morphogenesis.
Morphogenesis is totally inhibited when actinomycin
D is added at up to 4 hours after IFN-a and the
frequency of TRI is reduced when actinomycin D is
added before 12 hours21. These findings indicate
that TRI formation depends upon new RNA transcription.
Inhibition of protein synthesis by cycloheximide before 12 hours of IFN-a incubation also
blocks TRI formation; however after 12 hours of
IFN-a incubation, TRI formation is not significantly
blocked by cycloheximide21. The results suggest that
TRI morphogenesis may depend upon protein synthesized earlier than 12 hours.
Feedback inhibition of DNA replication and
blockage of S-phase by excess thymidine88 does not
block TRI formation; indeed, the proportion of TRI
increased when growth of Raji lymphoblastoid cells
was slowed by th midine synchronization prior to addition of IFN-a2 . As discussed above, halogenated
pyrimidines (BUdR, IUdR) actually induce the formation of TRI in a number of B cell lines16,28, presumably due to secondary stimulation of autogenous
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IFN-a production79,86.
It was of particular interest to test experimental effects of cytoskeletal paralysis, since the cytoskeleton is intimately involved in membrane flow and
translocation55 and also has been implicated in IFN-a
signal transduction6.
Poisons included deuterium
oxide (microtubule stabilizer)49,84, colchicine orvinblastine (microtubule depolymerizers) 84, and cytochalasin B (microfilament depolymerizer)29.
For
present studies, these were added before, with, or
after IFN-a (Table 2). Deuterium oxide (D2O) completely blocked, and the other drugs partially inhibited TRI morphogenesis. These results indicate that
integrity of cytoskeletal system is essential for the
TRI development in Daudi cells. Results with D2O
are especially important, since the inhibition of TRI
formation can thus be dissociated from some other
biological effects of IFN-a (see below).
Relation of TRI induction to
Biological Effects of IFN -a
Many medically significant biologic effects of
IFN-a occur within 12 hours after incubation.
In
contrast, the morphogenesis of TRI does not become
evident until 12 hours , and then only at relatively
high concentrations of IFN -a2 1. Inhibitor studies,
reviewed above, suggested tha t TRI morphogenesis
depends upon a prior accumulation of structural
proteins or of enzymes, but the exact sequence of
pre-morphogenetic events remains uncertain.
TRI and Anti - Viral Activity
The effect of IF N-a on establishment of an
antiviral state is nearly universal and not species
restricted.
The virus growth inhibition effect is
evident as early as 4 hours after incubation 1 , 74.
While almost all human cell lines with type 1 receptors are sensitive to an antiviral effect of IFN-a,
development of TRI is evidently not as universal: for
example, TRI were not found in A549 human lung
cancer cells or trisomy 21 fibrobl asts which are
endowed with abundant type 1 receptors2 l,46, 69.
TRI in NK effector cells
TRI can be mduced in human NK cells. This
was recently demonstrated by immunocytochemical
labelling with Leu lla+ or Leu 7 antibodies31,32,34;
however , the time scale for stimulation of NK cell
effector functions (binding to and lysis of target
cells) can precede TRI morphogenesis9, 62.
Growth Inhibition and TRI
Compared to either antiviral activity or NK
effector modulation, growth inhibition by IF N -a is a
relatively late effect and closely parallels TRI
formation both in highly sensitive Daudi lymphoblas toid cells and endothelial cell culturesl2,~1.
As
discussed above, however, the anti-proliferative and
morphogenic activities did not prove to be consistently linked: TRI also developed (but to a lesser
extent) in a Daudi mutant clone which selectively
resists the an ti-proliferative activity of IF N a21,53,83. Conversely, we have found that treatment
with 40% D20, which inhibits TRI morphogenesis,
does not prevent the IFN-a antiproliferative or 2'-5'
A synthetase induction activities (Tables 2, 3).
Again, this demonstrated that the phenomena could
be disassociated. Such results are not unexpected in
view of current hypotheses which implicate multiple
signal transduction pathways to explain the pleiotropic biologic actions of IFN-a13,53 after binding

Table 2.

Effect of Cytoskeletal Poisons on
TRI Formation

Inhibition#

Concentration

Cole hi cine

10-6M

-2 h
0 h
8 h

+
+
+

Vinblastine

10 - 6M

0 h

+

Cytochalasin B

10- 6M

0 h

+

40 %

-2 h
0 h

Time TRI at
added* 48 h

#All inhibitors purchased from Sigma Chemical Co.
St. Louis, MO. D2O prepared in 10 X RPMI 1640
(Gibco, Grand Island, NY) and diluted to appropriate
concentration.
*Time added after IFN-a (300 IU/ml). At this concentration TRI were induced in up to 10% of cell
sections in positive controls.

Table 3. Effects of D2O (40%) on growth and
2 '-5' AS induction of Daudi cells
treated with IFN-a (300 IU/ml)
Time*

Growth rate©
(72 h)

2'-5' AS#
(24 h)

-2 h

39%

7 to 11

X

0 h

70 %

7 to 11

X

8 h

55%

not tested

*Time after IFN -a added.
@compared to D2O controls at 72 h (mean of 2
experiments at each time point).
#specific activity of 2 '-5' A synthetase measured as
product of 2 '-5' A /mg protein/h compared to control
values for D2O treated or untreated cells without
IFN -a . Methods were described previously21. Control range of 2'-5' A produced in assay: 2.6 to 4.0
µ Mol/mg/h.
to a common set of type I receptors69.
TRI and 2 '-5' A Synthetase Induction
Induction of 2 '-5' A synthetase is the only IFNa-associated phenomenon which thus far has not been
uncoupled from TRI induction.
Elevated 2 '-5' A
synthetase was noted both in lymphoblastoid and
endothelial cell cultures which develop TRI12,21.
Actinomycin D and cycloheximide diminished induction of 2 '-5' A synthetase in parallel with inhibition
of TR121. Although smooth cytomembrane prol iferations in the liver~5 and in Chinese hamster endothelial cells previously have been associated with
excess enzyme induction30,61, the 2'-5' A system is
not membrane dependent48 and the relationship to
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TRI remains unclear.
Thymidine uptake
IFN-a blocks uptake of thymidine into many cell
types. This appears to be a direct effect on thymidine kinase, rather than a consequence of growth
inhibition14.
We have recently observed a similar
effect on amino acid and galactose transport into
Daudi cells after 12-24 hours incubation in IFN-a,
100 IU/ml (Rupp, B, Grimley, PM, unpublished data).
These phenomena probably are independent of TRI
formation. Feedback inhibition of DNA biosynthesis
by excess thymidine88 also had no effect on TRI
morphogenesis in Daudi cells.

This contrasted to the diminished uptake of 3H-TdR,
3H-galactose and 3H-amino acids (see above). Preliminary results of lipid extractions and high resolu tion thin layer chromatography58 further indicated
that specific incorporation of 3H-glycerol into
phosphatidyl choline increases two-fold between 4654 hours, at a time when TRI are accumulating
(Table 4).
Table 4. Thin layer chromatographic analysis of
Daud1 cells labelled with 3H-glycerol * at 46-54 hours
Treatment

CPM/mg dry Phosphatidyl Choline
weight**
specific activity©
(cpm/pMol)

Correlations of TRI Morphogenesis with
Effects on Macromolecular Metabolism
P:i·otein biosy nthesis
Studies of lymphoblasts treated with BUdR
indicated a shift in protein biosynthesis during TRI
formation 71
Gel electrophoretic analysis of hairy
leukemic cells which develop TRI after IFN-a treatment have shown induction of up to 16 proteins75,76.
Similar results have been reported with Daudi cells
after IFN-a treatment53.
Enzyme cytochemical
data79 indicate that TRI membranes are associated
with protein; however, the specificity and relation to
induction of specific proteins by IF N-a remains to be
determined.
Glycoprotein biosynthesis
Formation of massive TRI in the ER raises
questions regarding their possible functional effect
on cytosecretory activities. A role of TRI in immunoglobulin secretion was formerly postulated87, but
would not explain the development of TRI in T cells
or endothelium.
Daudi lymphoblastoid cells which
form abundant TRI also secrete IgM40; and they are
a promising model for testing effects of TRI on the
cytosecretory process. It has been shown that bio synthesis of IgM in Daudi cells diminishes during
IFN-a treatment27, but an effect of TRI morphogenesis on glycoprotein translocation through the
Golgi73 was not thereby excluded. In preliminary
studies, we hav e observed a reduction of total eel lular IgM in extracts of Daudi cells treated for 24 or
48 hours with IFN - a (Fig. 6). At up to 24 hours, we
could discern no general effect of IF N -a on the
pattern of glycoprotein biosynthesis in extracts of
cells analyzed by gradient gel electrophoresis after
labelling with 3H-galactose (Fig. 7). After 24 hours,
uptake of 3H-galactose was almost totally blocked
(Fig. 7); but Western blots for total IgM (Fig. 6)
failed to suggest any correlation of TRI with
accumulation of unlabelled glycoprotein.
This is
consistent with immunofluorescence evidence of slgM
down -regulation81.
Lipid Bio syn thesis
The role of lipids in TRI appears self-evident
from ultrastructural and cytochemical evidence. The
preservation of TRI membranes after KMn04 oxidation is particularly striking (Fig. 8) and favors the
concept of a phospholipid core structure77. In neonatal mice treated with interferon, there was a
marked increase in hepatic triglycerides accompanied
by a decrease in phospholipids89, and this may be
the counterpart of morphologic changes in the endoplasmic reticulum (see references 56, 57).
Using
Daudi cells treated with IFN-a, we found that total
uptake of 3H-glycerol is not decreased by IFN-a.

None

319

2.0

!Fa 100 IU/ml#

980

4.3

!Fa 1000 IU /ml#

899

5.1

3mM TdR

320

2.2

#mtrapure leukocyte interferon (Interferon Sciences,
New Brunswick, NJ).
*specific activity 33.7Ci/mM, concentration 5 µCi/ml
* *Pellet desiccated prior to extraction by Harth
method (58)
@Phospholipid bands identified by molybdenum blue
staining and quantitated by scanning densitometry
(58) . Radioactivity counted after scraping of bands
into organic scintillation fluid.
Clinical Pathogenesis of TRI
Despite the technical demands of TRI quantitation in ultra thin sections, detection of TRI in peripheral blood mononuclear cells has proven to be a
valid clinical parameter in evaluating groups of patients with persistently abnormal endogenous elevations of serum IFN-a (e.g., AIDS, systemic lupus ery thematosus)19,20,42,60. In AIDS, appearance of TRI
correlates strongly with disease progression, re due tion in T4 cells and production of endogenous acidlabile IFN-a19,20,60,65. In systemic lupus erythematosus, both prospective and retrospective analysis
have disclosed a positive correlation of TRI form a tion with abnormal serum levels of IFN-al9,42.
Disseminated TRI are most frequent in diseases
with high levels of endogenous interferon production44, 4"5; however, TRI have also been observed in a
number of other conditions, without measurable levels
of serum IFN-a85. Mechanisms for pathogenesis of
TRI probably include virus infections with localized
paracrine or autocrine IFa production7-9,54. TRI are
common in fetuses from gestations complicated by
rubella infection38, and may be associated with interferonogenic togavirus infections under experimen tal conditions15.
Cells chronically infected with
HIV-1 may induce formation of the acid labile alpha
interferon prevalent in AIDS5. A role of endotoxin
in stimulation of autogenous interferon production
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3
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43-

J

25Fig. 6. Western blot for IgM. Cells were extracted
with 0. 5 % Nonidet P-40 buffer and 2 mg of protein
were applied to each 0. 5 cm lane on a 6-12 % SD S
gradient gel for electrophoresis.
A nitrocellulose
blot was blocked with milk reagent, then reacted
with biotinylated goat polyclonal anti-IgM, and
developed with the Vector ABC method. Lanes 1 and
4: Daudi control cells at 24 and 48 hours. Lanes 2
and 5: Dau di cells treated with 500 IU /ml of IF N-a
for 24 and 48 hours. Lanes 3 and 6: H-9 (T-cell)
control cells at 24 and 48 hours.
Fig. 7. SDS 6-12% gradient gel electrophoresis of
Daud1 cells stabilized in Laemmeli buffer after 8
hours labelling with 3H-galactose at 46 hours (lane 1
- 4) or 16 hours (lane 5 - 8).
Control samples
(lanes 2, 6) and samples treated with 3mM thymidine
to inhibit growth (lanes 1, 5) were compared with
samples treated with IFN-a 100 IU/ml (lanes 3, 7) or
IFN-a 1000 IU/ml (Lanes 4, 8).
was recently demonstrated in NK cells and associated
with TRI formation48. Thus, the development of TRI
in human blood cells or solid tissues in infections,
auto-immune diseases and neoplasias may be stimulated by a wide variety of pathogenetic events rredisposing to local increases of interferon 7, 39, 5 .
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Discussion with Reviewers
H. Gamliel: Using immunoelectron microscopy we recorded changes in membrane antigens and receptors
of Daudi cells as early as 2 h after incubation with
1000 U/ml of IFN-a (see Gamliel H, Gurfel D, Wu
SH, Golomb HM, Interferon induced alterations in
hairy cells - a review, Scanning Microsc 2: 485-492,
1988). You state that TRI are detected only after 12
hours. It might be that these two types of types of
changes are totally unrelated, but could you exclude
the possibility that TRI are seen later because they
are not induced by IFN-a itself, but rather by some
other factor existing in the cultures. Did you use
gamma interferon, B-cell growth factor, anti-lFN-a
or other controls to prove that TRI are directly
induced by IFN-a?
Authors:
This raises an important, but complex
question. We previously learned that the delayed, Sphase effect of halogenated pyrimidines on TRI in duction28 was actually due to a secondary stimulation
of interferon production in the cultures86. Thus, it
is perfectly logical to inquire whether the delayed
effect of IF N -a itself reflects just another level in a
cascade of growth factors leading to TRI formation.
In our view, a cascade of subcellular biochemical
events (such as induction of 2'-5' A synthetase)
probably does precede TRI formation and account for
the delay in their morphogenesis, but this is not evidently due to the "feedback" and production of other
extracellular bioregulators such as gamma interferon.
This conclusion is based upon experimental induction
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of TRI in T-cells and endothelial cells which have
different growth factor binding affinities and sensitivities as compared to B-cells, and also upon failure
thus far to induce TRI with gamma interferon or
with IL-2, either directly or indirectly, by exposure
of lymphocytes to lectinsl 7.
Interestingly, betainterferon, which shares type I receptors with IFN-a,
does induce TRI. With regard to specificity, we have
used pure recombinant forms of IFN-a and blocked
-TRI induction with actinomycin D (this indicates
involvement of new mRNA transcription).
H. Gamliel: Studying TRI by means of transmission
electron microscopy bears the disadvantage of
screening only a thin slice of each cell. In hairy
cell leukemia we were unable to correctly determine
the percentages of cells displaying TRI formation.
Besides time-consuming serial sectioning, are there
other methods available for quantitating TRI in mixed
cell population?
Authors: A simpler method for quantitation of TRI
or component product has been a major objective of
our research, but we have thus far found no specific
radiolabel, immunolabel, or stain which can be detected by light optics. Conventional tissue processing
for light microscopy is unsatisfactory, since lipids
are extracted during embedding. Fixation of cells
with KMnO4 offers a useful alternative for elec tron
microscopic screening, since the TRI are thus high lighted (Fig. 8); but the counting of thin sections is
still tedious.
Incidentally, we prefer step rather
than serial sections, since the significance of differ ences in TRI counts is a binomial statistic. Based
upon the assumption of round cells , we previously
estimated broad ranges for significant differences in
TRI counts when at least 200 random thin sections
of separate cells were counted28. TRI counts of serial samples or multiple patient samples have been
successfully correlated with clinical data in double
blind studies20,42,60, and there have been good correlations in studies of IFN-a therapyl 7, 26. Despite
these results, we agree that development of a more
sensitive, quantitative detection method would be
more practical and more widely applicable in clinical
diagnosis, follow-up of disease progression or
evaluation of therapies.
A. Hiraoka:
The authors and their colleagues
suggested that TRI contain an acidic protein component77, and inhibitor tests indicated that TRI formation depends upon protein synthesis21. Among the
numerous complex changes induced by interferon
treatment, overall inhibition of protein synthesis and
increased synthesis of a specific group of proteins
has been noted. An analysis of protein synthesis and
patterns during TRI formation might aid in biochemical identification of TRI components. Have you ever
studied this relationship?
Authors: This is essential work which needs to be
pursued. As you point out, up to 16 induced proteins have been detected in extracts of leukemic
cells after IFN-a treatment53,75,76_ In patients with
hairy cell leukemia, protein induction by IFN-a can
continue for many days76 and parallel the increase
of TRI (Hiraoka A, Rosner MC, Golomb HM, In vitro
response of cells from three patients with haTry cell
leukemia to a recombinant leukocyte interferon.
Virchows Arch. [Bl 49: 73-82, 1985). One approach
might be to compare patterns of protein induction in

different cell lines which respond to interferon, but
only some of which produce TRI. Another approach
would be to analyze cell fractions. We have begun
some preliminary tests, but our main emphasis recently has been on the lipid studies.
J. Moss: The effect of interferon on lipid biosynthesis and thus membrane integrity does seem to contribute to the formation of endoplasmic reticulum abnormalities. It has been suggested that the interferon-induced tubular aggregates seen in neonatal
mice are the morphologic counterparts of biochemical
abnormalities of lipid biosynthesis56.
Authors: We certainly agree with this point; however, m contrast to the results from experimental
studies of suckling mice89; our data suggests that
TRI in Daudi cells may be associated with increased
phospholipid biosynthesis. As with CCC (see below),
there may be more than one ER membrane abnormal ity induced by IFN-a, perhaps depending on dose,
duration, or species.
H. Gamliel: You mention that in AIDS, CCC occur in
conjunction with TRI. Are the CCC linked physically
to TRI or do they just occur in the same cell with
no structural connections?
Authors : CCC represent abnormal cylindrical formations of the ER which appear to result from prolonged or excessive IFN-a exposure3,44. In AIDS,
CCC appear later than TRI and suggest a poor prognosis (Orenstein JM, Preble OT, Kind P, Schulof R.
The relationship of serum alpha-interferon and ultrastructural markers in HIV-seropositive individuals.
Ul trastruct. Pathol. 11: 673-679, 1987). Ultrastruc turally, TRI and CCC sometimes form in the same
cells44, and they can be entrapped within CCC,
presumably because they bc,th arise from the ER
(Kostianovsky M, ::ang Y-H, Grimley PM. Ultrastructural and immunoelectron microscopic studies of
cells with abnormal cytoplasmic inclusions in patients
with AIDS. AIDS Res. 1: 181-196 , 1984).
H. Gamliel: The paracrystalline structures you mention are quite different from the "classical" TRI.
Why are they placed in the same category? The fact
that both develop in response to human IFN-a treatment does not necessarily prove them to be identical
entities.
Authors: We long suspected a similarity of "classical" TRI and the paracrystalline or "geometric" TRI
and hypothesized a difference in tubule packing; the
tubule diameters are similar22,79. It is now evident
that both types of structures are induced by IFN-a;
however, only the "classical" form occurs in human
tissues. In the rhesus monkey, both forms of TRI
were observed after systemic IFN-a treatmentll and
this appeared to depend upon cell type (classical
form only in endothelium, paracrystalline forms in
fibroblasts and syncytial trophoblasts).
Work in
progress (D. Feldman and P. Grimley, unpublished)
shows that both forms may be induced in lymphoblast
cultures of subhuman primate origin. We agree that
such observations "beg the question" until a biochemical proof of identity becomes available. As in many
other morphologic studies, our interpretations are
based upon good circumstantial evidence.
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